Switching to farcical for patients with diabetic macular oedema

A recent study, published in the journal Nature looked into the six-month impact of switching neovascular age-related macular degeneration and diabetic macular oedema patients to faricimab instead of anti-VEGF therapy.

Advertisements



Latest Academic Articles

The latest academic articles from a wide range of themes such as energy, environment, health, agriculture, social sciences and technology plus more.

Open Access eBooks

The latest open access and free to distribute eBooks from key industry stakeholders covering health, energy, environment, plus more.

Horizon Europe

COP Climate Change

Special Reports